+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Peptide Therapeutics Market (by Type, Synthesis Technology, Manufacturing Type, Application & Region): Insights & Forecast with Potential Impact of COVID-19 (2021-2025)

  • ID: 5401887
  • Report
  • August 2021
  • Region: Global
  • 117 Pages
  • Koncept Analytics
10% Free customization
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

FEATURED COMPANIES

  • Amgen Inc.
  • Bristol Myers Squibb Co.
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Novartis International AG
  • PolyPeptide Group AG
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The global peptide therapeutics market is expected to record a value of US$42.22 billion in 2025, witnessing growth at a CAGR of 6.95%, for the duration spanning 2021-2025. The factors such as surging prevalence of cancer, rising healthcare expenditure, growing incidence of metabolic disorders, increasing geriatric population and accelerating number of approved peptide-based therapeutic drugs. However, the market growth would be challenged by availability of generic or biosimilar peptide therapeutic drugs, high cost of developing drugs and stringent regulatory requirements and production complexity of peptides. The market is anticipated to experience certain trends like expanding volume of peptides driven by generics, rapid adoption of outsourced peptide API and rising investments in research and development of novel drugs.




The global peptide therapeutics market can be segmented on the basis of type, synthesis technology, manufacturing type and application. Based on type, the market can be bifurcated into innovative and generic. According to synthesis technology, the market can be categorized into Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS) and Hybrid Technology. Whereas, on the basis of manufacturing type, the market can be divided outsourced and in-house. In terms of application, the global peptide therapeutics market can be split into chemotherapy, gastroenterology, analgesia, diabetes, paediatric & neonatology and other applications.


The fastest growing regional market is North America due to increasing research and development activities for the development of innovative peptide therapeutics and improvements in healthcare infrastructure coupled with growing prescription of peptide therapeutics on account of high presence of a large number of patients with chronic diseases such as diabetes and cancer.


Scope of the report

  • The report provides a comprehensive analysis of the global peptide therapeutics market segmented on the basis of type, synthesis technology, manufacturing type and application region.
  • The major regional and country markets (North America, Europe, Middle East & Africa, Asia Pacific and Latin America) have been analyzed.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Novartis International AG, GlaxoSmithKline PLC, Bristol Myers Squibb Co., Amgen Inc., Eli Lilly and Company and PolyPeptide Group AG) are also presented in detail.

Key Target Audience

  • Peptide Manufacturers, Suppliers & Distributors
  • Pharmaceutical, Biopharmaceutical & Biotechnological Companies
  • Research and Development (R&D) Organizations
  • Government Bodies & Regulating Authorities
Frequently Asked Questions about the Global Peptide Therapeutics Market

What is the estimated value of the Global Peptide Therapeutics Market?

The Global Peptide Therapeutics Market was estimated to be valued at $32.3 Billion in 2021.

What is the growth rate of the Global Peptide Therapeutics Market?

The growth rate of the Global Peptide Therapeutics Market is 6.9%, with an estimated value of $42.2 Billion by 2025.

What is the forecasted size of the Global Peptide Therapeutics Market?

The Global Peptide Therapeutics Market is estimated to be worth $42.2 Billion by 2025.

Who are the key companies in the Global Peptide Therapeutics Market?

Key companies in the Global Peptide Therapeutics Market include Amgen Inc., Bristol Myers Squibb Co., Eli Lilly and Company, GlaxoSmithKline PLC and PolyPeptide Group AG.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen Inc.
  • Bristol Myers Squibb Co.
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Novartis International AG
  • PolyPeptide Group AG

1. Market Overview
1.1 Introduction
1.2 Manufacturing Process of Peptides
1.3 Classification of Peptides
1.4 Functional Classification of Therapeutic Peptides & Proteins
1.5 Examples of Peptide-based Drugs
1.6 Advantages and Disadvantages of Therapeutic Peptides
1.7 Source or Chemical Nature of Early Peptides


2. Impact of COVID-19
2.1 Adoption of Peptides in COVID-19 Related Research
2.2 Disruptions in Clinical Trials


3. Market Analysis
3.1 Global Peptide Therapeutics Market by Value
3.2 Global Peptide Therapeutics Market Forecast by Value
3.3 Global Peptide Therapeutics Market by Type
3.3.1 Global Innovative Peptide Therapeutics Market by Value
3.3.2 Global Innovative Peptide Therapeutics Market Forecast by Value
3.3.3 Global Generic Peptide Therapeutics Market by Value
3.3.4 Global Generic Peptide Therapeutics Market Forecast by Value
3.4 Global Peptide Therapeutics Market by Synthesis Technology
3.4.1 Global Solid Phase Peptide Synthesis Therapeutics Market by Value
3.4.2 Global Solid Phase Peptide Synthesis Therapeutics Market Forecast by Value
3.4.3 Global Liquid Phase Peptide Synthesis Therapeutics Market by Value
3.4.4 Global Liquid Phase Peptide Synthesis Therapeutics Market Forecast by Value
3.4.5 Global Hybrid Technology Synthesis Therapeutics Market by Value
3.4.6 Global Hybrid Technology Synthesis Therapeutics Market Forecast by Value
3.5 Global Peptide Therapeutics Market by Manufacturing Type
3.5.1 Global Outsourced Peptide Therapeutics Market Forecast by Value
3.5.2 Global In-house Peptide Therapeutics Market Forecast by Value
3.6 Global Peptide Therapeutics Market by Application
3.6.1 Global Metabolic Disorders Peptide Therapeutics Market by Value
3.6.2 Global Metabolic Disorders Peptide Therapeutics Market Forecast by Value
3.6.3 Global Oncology Peptide Therapeutics Market by Value
3.6.4 Global Oncology Peptide Therapeutics Market Forecast by Value
3.6.5 Global Gastrointestinal Disorders Peptide Therapeutics Market by Value
3.6.6 Global Gastrointestinal Disorders Peptide Therapeutics Market Forecast by Value
3.6.7 Global Cardiovascular Disorders Peptide Therapeutics Market by Value
3.6.8 Global Cardiovascular Disorders Peptide Therapeutics Market Forecast by Value
3.6.9 Global Neurological Disorders Peptide Therapeutics Market by Value
3.6.10 Global Neurological Disorders Peptide Therapeutics Market Forecast by Value
3.7 Global Peptide Therapeutics Market by Region


4. Regional Market
4.1 North America
4.1.1 North America Peptide Therapeutics Market by Value
4.1.2 North America Peptide Therapeutics Market Forecast by Value
4.1.3 The U.S. Peptide Therapeutics Market Forecast by Value
4.1.4 The U.S. Peptide Therapeutics Market Forecast by Type
4.2 Europe, Middle East & Africa
4.2.1 Europe, Middle East & Africa Peptide Therapeutics Market by Value
4.2.2 Europe, Middle East & Africa Peptide Therapeutics Market Forecast by Value
4.3 Asia Pacific
4.3.1 Asia Pacific Peptide Therapeutics Market by Value
4.3.2 Asia Pacific Peptide Therapeutics Market Forecast by Value
4.4 Latin America
4.4.1 Latin America Peptide Therapeutics Market by Value
4.4.2 Latin America Peptide Therapeutics Market Forecast by Value


5. Market Dynamics
5.1 Growth Drivers
5.1.1 Surging Prevalence of Cancer
5.1.2 Rising Healthcare Expenditure
5.1.3 Growing Incidence of Metabolic Disorders
5.1.4 Increasing Geriatric Population
5.1.5 Accelerating Number of Approved Peptide-based Therapeutic Drugs
5.2 Key Trends and Developments
5.2.1 Expanding Volume of Peptides driven by Generics
5.2.2 Rapid Adoption of Outsourced Peptide API
5.2.3 Rising Investments in Research and Development of Novel Drugs
5.3 Challenges
5.3.1 Availability of Generic or Biosimilar Peptide Therapeutic Drugs
5.3.2 High Cost of Developing Drugs and Stringent Regulatory Requirements
5.3.3 Production Complexity of Peptides


6. Competitive Landscape
6.1 Global Market
6.1.1 Revenue Comparison of Key Players
6.1.2 Market Capitalization Comparison of Key Players
6.1.3 R&D Comparison of Key Players


7. Company Profiles
7.1 Novartis International AG
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 GlaxoSmithKline PLC
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Bristol Myers Squibb Co.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 Amgen Inc.
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies
7.5 Eli Lilly and Company
7.5.1 Business Overview
7.5.2 Financial Overview
7.5.3 Business Strategies
7.6 PolyPeptide Group AG
7.6.1 Business Overview
7.6.2 Financial Overview
7.6.3 Business Strategies


List of Charts
Manufacturing Process of Peptides
Classification of Peptides
Functional Classification of Therapeutic Peptides & Proteins
Advantages and Disadvantages of Therapeutic Peptides
Global Most Affected Clinical Trials by Therapy Area (2020)
Global Peptide Therapeutics Market by Value (2016-2020)
Global Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Peptide Therapeutics Market by Type (2020)
Global Innovative Peptide Therapeutics Market by Value (2016-2020)
Global Innovative Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Generic Peptide Therapeutics Market by Value (2016-2020)
Global Generic Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Peptide Therapeutics Market by Synthesis Technology (2020)
Global Solid Phase Peptide Synthesis Therapeutics Market by Value (2016-2020)
Global Solid Phase Peptide Synthesis Therapeutics Market Forecast by Value (2021-2025)
Global Liquid Phase Peptide Synthesis Therapeutics Market by Value (2016-2020)
Global Liquid Phase Peptide Synthesis Therapeutics Market Forecast by Value (2021-2025)
Global Hybrid Technology Synthesis Therapeutics Market by Value (2016-2020)
Global Hybrid Technology Synthesis Therapeutics Market Forecast by Value (2021-2025)
Global Peptide Therapeutics Market by Manufacturing Type (2020)
Global Outsourced Peptide Therapeutics Market Forecast by Value (2020-2025)
Global In-house Peptide Therapeutics Market Forecast by Value (2020-2025)
Global Peptide Therapeutics Market by Application (2020)
Global Metabolic Disorders Peptide Therapeutics Market by Value (2016-2020)
Global Metabolic Disorders Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Oncology Peptide Therapeutics Market by Value (2016-2020)
Global Oncology Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Gastrointestinal Disorders Peptide Therapeutics Market by Value (2016-2020)
Global Gastrointestinal Disorders Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Cardiovascular Disorders Peptide Therapeutics Market by Value (2016-2020)
Global Cardiovascular Disorders Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Neurological Disorders Peptide Therapeutics Market by Value (2016-2020)
Global Neurological Disorders Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Peptide Therapeutics Market by Region (2020)
North America Peptide Therapeutics Market by Value (2016-2020)
North America Peptide Therapeutics Market Forecast by Value (2021-2025)
The U.S. Peptide Therapeutics Market Forecast by Value (2020-2025)
The U.S. Peptide Therapeutics Market by Type (2020-2025)
Europe, Middle East & Africa Peptide Therapeutics Market by Value (2016-2020)
Europe, Middle East & Africa Peptide Therapeutics Market Forecast by Value (2021-2025)
Asia Pacific Peptide Therapeutics Market by Value (2016-2020)
Asia Pacific Peptide Therapeutics Market Forecast by Value (2021-2025)
Latin America Peptide Therapeutics Market by Value (2016-2020)
Latin America Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Cancer Prevalence (2018-2023)
Global Healthcare Expenditure Per Capita (2016-2020)
Global Diabetes Prevalence (2010-2045)
Global Population Ages 65 Years and Above (2016-2020)
Number of Approved/Launched Peptide Therapeutic Drugs Worldwide (2020-2025)
Global GLP-1 Market Development (2018-2027)
Global In-House vs. Outsourced Peptide API Market Development (2020-2025)
Global Spending on Pharmaceutical Research and Development (2018-2026)
Global Biosimilar Therapeutic Peptides Market (2020-2025)
Novartis International AG Net Sales and Net Income (2016-2020)
Novartis International AG Net Sales by Segment (2020)
Novartis International AG Net Sales by Region (2020)
GlaxoSmithKline PLC Turnover and Profit (2016-2020)
GlaxoSmithKline PLC Turnover by Segment (2020)
GlaxoSmithKline PLC Turnover by Region (2020)
Bristol Myers Squibb Co. Total Revenue and Net Earnings (2016-2020)
Bristol Myers Squibb Co. Total Revenue by Region (2020)
Amgen Inc. Revenue and Net Income (2016-2020)
Amgen Inc. Revenue by Region (2020)
Eli Lilly and Company Revenue and Net Income (2016-2020)
Eli Lilly and Company Revenue by Region (2020)
PolyPeptide Group AG Revenue and Net Income (2018-2020)
PolyPeptide Group AG Revenue by Segment (2020)
PolyPeptide Group AG Revenue by Region (2020)


List of Tables
Difference between Peptides, Small Molecules & Biologics
Examples of Peptide-based Drugs Available in the Market
Source or Chemical Nature of Early Peptides
Synthetic Peptides in Development of COVID-19 (2020)
Revenue Comparison of Key Players (2020)
Market Capitalization Comparison of Key Players (2021)
R&D Comparison of Key Players (2020)
Note: Product cover images may vary from those shown
  • Amgen Inc.
  • Bristol Myers Squibb Co.
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Novartis International AG
  • PolyPeptide Group AG
Note: Product cover images may vary from those shown

Loading
LOADING...